SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 127 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $94,000 | -20.3% | 20,220 | -0.6% | 0.02% | +4.5% |
Q2 2016 | $118,000 | -78.5% | 20,352 | -77.6% | 0.02% | -72.2% |
Q1 2016 | $550,000 | +107.5% | 90,971 | +93.7% | 0.08% | +203.8% |
Q3 2015 | $265,000 | -43.5% | 46,971 | +11.0% | 0.03% | -43.5% |
Q2 2015 | $469,000 | +191.3% | 42,311 | +300.6% | 0.05% | +206.7% |
Q4 2014 | $161,000 | -23.0% | 10,561 | -45.6% | 0.02% | -16.7% |
Q3 2014 | $209,000 | -91.5% | 19,425 | -87.9% | 0.02% | -90.7% |
Q2 2014 | $2,457,000 | +845.0% | 160,922 | +759.9% | 0.19% | +1508.3% |
Q4 2013 | $260,000 | – | 18,714 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |